Acta Psychiatr Scand 2015;132(4):231-40 Bonn U
Peptide-related therapies discussed on this website may not be approved by the U.S
Reported side effects The side effects reported in trials and research protocols tend to be mild and transient: Common: Injection site reactions: redness, swelling, mild irritation at the injection location Headache: reported in some subjects, typically mild and temporary Mild gastrointestinal discomfort: occasional reports of nausea or upset stomach Less common: Temporary dizziness Slight increases in heart rate Minor liver enzyme elevations in some subjects These effects, when they occur, generally resolve without intervention and don't require discontinuation
The Cerebrolysin Bias: Stability, Recovery, and GDNF Growth Research indicates that in cortical tissue models, Cerebrolysin demonstrates a massive capacity to sustain and boost GDNF along with a broad range of other survival proteins
Neurological Effects : AOD 9604 peptide shows minimal neurological side effects compared to compounds that cross the blood-brain barrier more readily
MOTS-c directly addresses these mechanisms